Tranche Update on Suzuken Co., Ltd.'s Equity Buyback Plan announced on November 10, 2023.
January 24, 2024 at 07:30 am IST
Share
From January 1, 2024 to January 23, 2024, the company has repurchased 817,400 shares, representing 0.99% for ¥3,923.17 million. With this, the company has completed the repurchase of 5,124,900 shares, representing 6.19% for ¥24,999.95 million under the buyback announced on November 10, 2023.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN CO., LTD. 
